AzTrials
AzTrials

Meatal StenosisNCT07424651

Hidden Link Between Meatal Stenosis and Primary Nocturnal Enuresis in Children

An observational study of Meatal Stenosis and Primary Nocturnal Enuresis, run by New Valley University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to investigate the association between meatal stenosis and primary nocturnal enuresis severity, and evaluated therapeutic outcomes following surgical correction. Read more about this study

Who is it for?
Ages 7 to 12 years, men only
What is being tested?
Meatoplasty Primary nocturnal enuresis.
Type of treatment
Surgery or procedure
How many people
400 participants
Where
1 siteEgypt
Study dates
31 Jan 2021to 10 Mar 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • Men only
  • No healthy volunteers
  • Child

Study population: This retrospective study population includes male children aged 7-12 years who presented with primary nocturnal enuresis at a pediatric urology clinic between October 2022 and December 2024.

Who may be able to join

  • Male children aged 7-12 years.
  • Diagnosed with primary nocturnal enuresis.
  • Evaluated and treated at the study center between January 2021 and December 2024.
  • Confirmed diagnosis of meatal stenosis based on clinical examination and uroflowmetry when indicated.
  • Patients who underwent meatoplasty and completed the prescribed follow-up period.

Who cannot join

  • Secondary enuresis (previously dry for ≥ 6 months before recurrence of bedwetting).
  • Known neurological disorders (e.g., spina bifida, cerebral palsy) or developmental delays.
  • Structural anomalies of the urinary tract other than meatal stenosis (e.g., posterior urethral valves, vesicoureteral reflux).
  • Children who did not complete the follow-up or had incomplete clinical records.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • New Valley University

    New Valley, Cairo Governorate, 72511

Other trials in Egypt

About this study

Official title: Investigating the Hidden Link Between Meatal Stenosis and Primary Nocturnal Enuresis in Children

This study aimed to investigate the association between meatal stenosis and primary nocturnal enuresis severity, and evaluated therapeutic outcomes following surgical correction.

Read the detailed description

Primary nocturnal enuresis (PNE) is a prevalent pediatric condition characterized by involuntary urination during sleep in children aged five years or older who have never achieved consistent nighttime dryness. The prevalence of PNE decreases with age, affecting approximately 15% of five-year-old and decreasing to 1-2% by adolescence.

Meatal stenosis, defined as the pathological narrowing of the urethral meatus, is an underexplored potential factor. This condition is known to cause obstructed urinary flow, incomplete bladder emptying, and increased bladder pressure, all of which may contribute to enuresis.

The incidence of meatal stenosis is higher in circumcised males but can also occur in uncircumcised males and females due to inflammation, trauma, or infection

Being tested
Meatoplasty Primary nocturnal enuresis.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Meatoplasty Primary nocturnal enuresis.Procedure or surgery

    Patients diagnosed with primary nocturnal enuresis.

Study groups in NCT07424651
Study groupRoleWhat they receive
Study groupPatients who underwent meatoplasty.
Receives: Procedure: Meatoplasty Primary nocturnal enuresis.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association between Meatal Stenosis and primary nocturnal enuresis

    Association between Meatal Stenosis and primary nocturnal enuresis was assessed to determine whether there is a significant relationship between the presence of meatal stenosis and the occurrence of primary nocturnal enuresis in male children aged 7-12 years.

    Measured: 3 years from collecting the data from the database

Secondary outcomes (4)
  1. Resolution of primary nocturnal enuresis post-meatoplasty

    Resolution of primary nocturnal enuresis post-meatoplasty was assessed to assess the effectiveness of meatoplasty in resolving primary nocturnal enuresis in children with meatal stenosis.

    Measured: 3 years from collecting the data from the database

  2. Need for Revision Meatoplasty

    Need for Revision Meatoplasty was assessed in patients due to persistent or recurrent meatal stenosis after the initial surgery.

    Measured: 3 years from collecting the data from the database

  3. Prevalence of Meatal Stenosis in primary nocturnal enuresis patients

    Prevalence of Meatal Stenosis in primary nocturnal enuresis patients was assessed among children diagnosed with primary nocturnal enuresis within the study period (2021-2024).

    Measured: 3 years from collecting the data from the database

  4. Incidence of complications

    Any complications or adverse events following meatoplasty, including infection, scarring, or urinary retention were recorded.

    Measured: 3 years from collecting the data from the database

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2026
  2. Study start31 Jan 2021
  3. Primary completion10 Mar 2025
  4. Study completion10 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07424651
Sponsor's protocol ID
2025130002
Status last verified
Feb 2026
First submitted
14 Feb 2026
Last updated
20 Feb 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

An observational study of Meatal Stenosis and Primary Nocturnal Enuresis, run by New Valley University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association between Meatal Stenosis and primary nocturnal enuresis (time frame: 3 years from collecting the data from the database). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in